Login / Signup

Circulating tumour DNA and its clinical utility in predicting treatment response or survival in patients with metastatic colorectal cancer: a systematic review and meta-analysis.

Louise Bach CallesenJulian HamfjordAnders K BoysenNiels PallisgaardTormod Kyrre GurenElin H KureKaren-Lise Garm Spindler
Published in: British journal of cancer (2022)
Plasma ctDNA is a strong prognostic biomarker in mCRC. However, true clinical utility is lacking.
Keyphrases
  • metastatic colorectal cancer
  • circulating tumor
  • cell free
  • circulating tumor cells
  • single molecule
  • free survival
  • nucleic acid